There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been ...

Three sectors stand out for their exceptional potential: defense, energy, and pharmaceuticals. This momentum is represented in the pharmaceutical industry, where research laboratories still buy ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...